🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Assessment of Treatment Adherence and Associated Factors in Chronic HepB Patients Supported by HBVCare

RecruitingNAAges 18 Years - anyAllInstitute of Gastroenterology and Hepatology, Vie…
NCT07540637 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Adherence to chronic Hepatitis B (HBV) treatment and regular follow-up visits is essential for preventing dangerous complications, yet adherence rates in Vietnam remain low due to barriers in patient awareness and geographic conditions. Digital health solutions, particularly mobile applications, have shown potential as tools for supporting patients in proactive disease management. The HBVCare mobile application was developed to provide features such as medication reminders, storage of lab results, and health education to improve treatment adherence and clinical outcomes. The investigators are conducting a multicenter, randomized controlled trial at Hoang Long Clinic and Hanoi Medical University Hospital to evaluate the effectiveness of HBVCare. Patients are randomized into either a control group receiving standard care and an intervention group using the HBVCare app, with patient adheren

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age ≥ 18 years. * Diagnosis of Chronic Hepatitis B (CHB): HBsAg (+) and/or HBV DNA positive for ≥ 6 months; Or HBsAg positive and anti-HBc IgM negative. * Smartphone ownership (iOS or Android) with an active internet connection and the ability to install the HBVCare application. * Sufficient literacy to read and understand Vietnamese and respond to study questions. * Provision of informed consent to participate in the study. Exclusion Criteria: * Mental health disorders, cognitive impairment, or difficulties in communication and mobile application usage. * Severe comorbid chronic conditions, such as heart failure, kidney failure, or respiratory failure. * Presence of severe complications, including gastrointestinal bleeding, liver cancer, hepatic encephalopathy, or acute liver failure.
💊

What it tests

  • HBVCare Mobile App
📍

Where

2 sites
Hanoi Medical University Hospital
Hanoi, Vietnam
Institute of Gastroenterology and Hepatology
Hanoi, Vietnam
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy